Tens Of Thousands To Benefit From English Funding Nod For siRNA Cholesterol Drug Leqvio
The NHS Will Commission The Drug’s Rollout ‘With Immediate Effect’
A landmark population-level agreement between Novartis and the National Health Service for the gene silencing therapy Leqvio is now being implemented following the thumbs up from health technology assessment body NICE.
You may also be interested in...
Patients in England with non-small cell lung cancer will be the first In Europe to be offered Amgen’s KRAS G12C inhibitor.
A total of six medicines were recommended for use on the National Health Service in Scotland in August.
The innovative collaboration should accelerate access to the first-in-class cholesterol lowering drug acquired with The Medicines Company buy.